The largest, most ethnically diverse, study of its kind has flagged hundreds of genetic variants that play a role in ...

Major depressive disorder (MDD) is a debilitating mental health condition characterized by persistent low mood, loss of ...

Johnson & Johnson's ketamine-derived nasal spray has been approved as a standalone treatment to fight depression for those ...

Johnson & Johnson has announced a major breakthrough in mental health treatment. The Food and Drug Administration (FDA) has approved Spravato, a novel nasal spray, for the standalone treatment of ...

Many Canadians struggle with SAD, a real form of depression that can make navigating the winter months extremely difficult.

The announcement was welcome news for those with major depressive disorder, affecting an estimated 8.3% of the adult ...

Spravato, okayed for stand-alone use among adults, is the first such therapy for major depressive disorder (MDD) that is ...

Using computational models, the researchers studied how the brain’s reward-learning system functions in those with depression ...

Seasonal affective disorder (SAD) is a type of recurrent depressive periods that occur during the same season each year. SAD ...

A one-time nasal spray has been approved by the Food and Drug Administration as a standalone treatment for depression.

The FDA has approved a supplemental new drug application for Spravato, an esketamine nasal spray that can be used as ...

It's become increasingly clear that the gut microbiome can affect human health, including mental health. Which bacterial ...